Full Text View
Tabular View
No Study Results Posted
Related Studies
Zoledronic Acid for Osteoporosis in the Elderly (ZEST)
This study is ongoing, but not recruiting participants.
Study NCT00558012   Information provided by University of Pittsburgh

First Received on November 13, 2007.   Last Updated on December 12, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoporosis
Bone Loss
Fragility Fractures
Additional conditions recognized in this trial
Fractures, Bone
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Musculoskeletal Diseases
Wounds and Injuries
Interventions listed in this trial
Intravenous zoledronic acid
Additional drug interventions recognized in this trial
Diphosphonates
Zoledronic acid
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of Pittsburgh
National Institutes of Health (NIH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services